DE69222444T2 - Substituierte 1,2,3,4-Tetrahydrocyclopent[b]indole, 1,2,3,3a,4,8a-Hexahydrocyclopent[b]indole und verwandte Verbindungen, Zwischenprodukte und ein Verfahren zur Herstellung derselben und ihre Verwendung als Medikamente - Google Patents

Substituierte 1,2,3,4-Tetrahydrocyclopent[b]indole, 1,2,3,3a,4,8a-Hexahydrocyclopent[b]indole und verwandte Verbindungen, Zwischenprodukte und ein Verfahren zur Herstellung derselben und ihre Verwendung als Medikamente

Info

Publication number
DE69222444T2
DE69222444T2 DE69222444T DE69222444T DE69222444T2 DE 69222444 T2 DE69222444 T2 DE 69222444T2 DE 69222444 T DE69222444 T DE 69222444T DE 69222444 T DE69222444 T DE 69222444T DE 69222444 T2 DE69222444 T2 DE 69222444T2
Authority
DE
Germany
Prior art keywords
phenyl
alkyl
formula
compound
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69222444T
Other languages
German (de)
English (en)
Other versions
DE69222444D1 (de
Inventor
Michael Clayton Merriman
Gerard Joseph O'malley
Helen Hu Ong
Mark Gabriel Palermo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of DE69222444D1 publication Critical patent/DE69222444D1/de
Publication of DE69222444T2 publication Critical patent/DE69222444T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69222444T 1991-01-18 1992-01-18 Substituierte 1,2,3,4-Tetrahydrocyclopent[b]indole, 1,2,3,3a,4,8a-Hexahydrocyclopent[b]indole und verwandte Verbindungen, Zwischenprodukte und ein Verfahren zur Herstellung derselben und ihre Verwendung als Medikamente Expired - Lifetime DE69222444T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/642,952 US5100891A (en) 1991-01-18 1991-01-18 Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds

Publications (2)

Publication Number Publication Date
DE69222444D1 DE69222444D1 (de) 1997-11-06
DE69222444T2 true DE69222444T2 (de) 1998-06-04

Family

ID=24578739

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69222444T Expired - Lifetime DE69222444T2 (de) 1991-01-18 1992-01-18 Substituierte 1,2,3,4-Tetrahydrocyclopent[b]indole, 1,2,3,3a,4,8a-Hexahydrocyclopent[b]indole und verwandte Verbindungen, Zwischenprodukte und ein Verfahren zur Herstellung derselben und ihre Verwendung als Medikamente

Country Status (26)

Country Link
US (1) US5100891A (show.php)
EP (1) EP0496314B1 (show.php)
JP (1) JP2665422B2 (show.php)
KR (1) KR100230881B1 (show.php)
AT (1) ATE158790T1 (show.php)
AU (1) AU650315B2 (show.php)
BR (1) BR9200171A (show.php)
CA (1) CA2059610C (show.php)
CZ (1) CZ282732B6 (show.php)
DE (1) DE69222444T2 (show.php)
DK (1) DK0496314T3 (show.php)
ES (1) ES2109953T3 (show.php)
FI (2) FI102174B (show.php)
GR (1) GR3025318T3 (show.php)
HU (1) HUT67027A (show.php)
IE (1) IE920149A1 (show.php)
IL (1) IL100693A0 (show.php)
MX (1) MX9200206A (show.php)
NO (1) NO178397C (show.php)
NZ (1) NZ241305A (show.php)
PH (1) PH31429A (show.php)
PL (2) PL167465B1 (show.php)
RO (1) RO112505B1 (show.php)
RU (1) RU2077530C1 (show.php)
TW (1) TW198024B (show.php)
ZA (1) ZA92341B (show.php)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298626A (en) * 1991-01-18 1994-03-29 Hoechst-Roussel Pharmaceuticals Incorporated Select cyclopent[b]indoles
US5350762A (en) * 1993-03-08 1994-09-27 Hoechst-Roussel Pharmaceuticals Incorporated Tetrahydrocyclopent[B]indole methanamines and related compounds
AU735249B2 (en) * 1997-07-03 2001-07-05 Asahi Kasei Kabushiki Kaisha Novel tricyclic compounds having saturated rings and medicinal compositions containing the same
TWI220143B (en) * 1998-05-13 2004-08-11 Solvay Pharm Gmbh Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds and novel cyclic compounds, and intermediate products
UA69420C2 (uk) * 1998-10-06 2004-09-15 Янссен Фармацевтика Н.В. ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ
UA70334C2 (en) * 1998-10-06 2004-10-15 Janssen Pharmaceutica N V Jans BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS
ATE269337T1 (de) * 1998-10-06 2004-07-15 Janssen Pharmaceutica Nv Trizyclische delta3-pyridine als arzneimittel
IT1317926B1 (it) * 2000-11-03 2003-07-15 Sigma Tau Ind Farmaceuti Derivati triciclici dell'indolo ad attivita' antiangiogenica.
EP1654228B1 (en) 2003-06-10 2008-10-22 Smithkline Beecham Corporation Tetrahydrocarbazole derivatives and their pharmaceutical use
ES2327416T3 (es) 2003-06-12 2009-10-29 Smithkline Beecham Corporation Derivados de tetraidrocarbazol y su uso farmaceutico.
EP1817025A2 (en) * 2004-11-23 2007-08-15 PTC Therapeutics, Inc. Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control
GB2422828A (en) * 2005-02-03 2006-08-09 Hunter Fleming Ltd Tricyclic cytoprotective compounds comprising an indole residue
WO2013139929A1 (en) * 2012-03-22 2013-09-26 Ludwig-Maximilians-Universität München Novel means and methods for treating diseases of the central nervous system, metabolic and cardiac diseases and aging
KR20140013471A (ko) 2012-07-24 2014-02-05 주식회사 쎄코 진공증착용 발열조립체 및 이를 구비하는 진공증착장치
US10882821B1 (en) 2017-09-26 2021-01-05 The Board Of Trustees Of The Leland Stanford Junior University Enantiomeric compound for the reduction of the deleterious activity of extended nucleotide repeat containing genes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3514462A (en) * 1966-10-21 1970-05-26 Upjohn Co 1 and 2 ethoxy 3,4,5,10 - tetrahydroazepino(3,4-b) and (2,3-b)indoles and corresponding amino derivatives thereof
US3595874A (en) * 1969-02-28 1971-07-27 Upjohn Co 3,4,5,10-tetrahydroazepino(2,3-b)indol-5a (2h)-ols
BE787537A (fr) * 1971-08-16 1973-02-14 Sterling Drug Inc Tetrahydrocarbazoles
SU482086A1 (ru) * 1973-11-30 1976-03-15 Всесоюзный Научно-Исследовательски% Химико-Фармацевтический Институт Им.С.Орджоникидзе Способ получени производных 1- -амино1,2,3,4-тетрагидрокарбазола
JPS5111760A (show.php) * 1974-06-18 1976-01-30 Ayerst Mckenna & Harrison
US4254134A (en) * 1978-03-17 1981-03-03 Endo Laboratories, Inc. Antidepressant 2-amino- and -2-(substituted amino)-cis-hexahydro-carbazoles

Also Published As

Publication number Publication date
FI20001775L (fi) 2000-08-10
KR100230881B1 (ko) 1999-11-15
MX9200206A (es) 1992-08-01
DK0496314T3 (da) 1998-05-18
KR920014777A (ko) 1992-08-25
FI920192L (fi) 1992-07-19
PH31429A (en) 1998-11-03
AU650315B2 (en) 1994-06-16
RU2077530C1 (ru) 1997-04-20
JPH04334367A (ja) 1992-11-20
CZ282732B6 (cs) 1997-09-17
FI102174B1 (fi) 1998-10-30
AU1027992A (en) 1992-07-23
HUT67027A (en) 1995-01-30
IL100693A0 (en) 1992-09-06
TW198024B (show.php) 1993-01-11
ZA92341B (en) 1992-09-30
DE69222444D1 (de) 1997-11-06
IE920149A1 (en) 1992-07-29
PL169417B1 (pl) 1996-07-31
BR9200171A (pt) 1992-10-06
FI107919B (fi) 2001-10-31
NO178397C (no) 1996-03-20
US5100891A (en) 1992-03-31
NO920235D0 (no) 1992-01-17
RO112505B1 (ro) 1997-10-30
NO178397B (no) 1995-12-11
CA2059610A1 (en) 1992-07-19
NO920235L (no) 1992-07-20
JP2665422B2 (ja) 1997-10-22
CS12992A3 (en) 1992-08-12
EP0496314B1 (en) 1997-10-01
ATE158790T1 (de) 1997-10-15
FI102174B (fi) 1998-10-30
HU9200172D0 (en) 1992-04-28
PL167465B1 (pl) 1995-09-30
EP0496314A1 (en) 1992-07-29
PL296651A1 (en) 1993-07-26
GR3025318T3 (en) 1998-02-27
FI920192A0 (fi) 1992-01-16
CA2059610C (en) 2002-04-02
ES2109953T3 (es) 1998-02-01
PL293209A1 (en) 1993-04-05
NZ241305A (en) 1994-10-26

Similar Documents

Publication Publication Date Title
DE3750596T2 (de) 1,2,3,3a,8,8a-Hexahydro-1,3a,8-Trimethylpyrrolo[2,3-b]indole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
DE69800896T2 (de) 8-substituierte-1,3,8-Triazaspiro[4,5]decan-4-onderivate
DE69418789T2 (de) 2-(Piperidin-4-yl, Pyridin-4-yl und Tetrahydropyridin-4-yl)-benzofuran-7-carbamat Derivate, ihre Herstellung und Verwendung als Acetylcholinesterase Inhibitoren
DE69025941T2 (de) Dem Physostigmin verwandte 4- und 6-Carbamate, ein Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE69332691T2 (de) Substituierte 3-(aminoalkylamino)-1,2-benzisoxazole und verwandte verbindungen
DE3852335T2 (de) N-(Pyridinyl)-1H-indol-1-amine, Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel.
DE69231817T2 (de) Carbamatderivate von 4-Amino-3-Isoxazolidinonen und 3-Amino-1-Hydroxypyrrolidinon-2-onen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE69016530T2 (de) 1,3-Dihydro-1-(pyridinylamino)-2H-indol-2-one, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
DE69028605T2 (de) Aminocarbonylcarbamate verwandt mit Physostigmin, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE69211892T2 (de) 1-(Pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-Indole, Zwischenprodukte und ein Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE69118470T2 (de) Substituierte 4-amino-3-pyridinolen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE69206889T2 (de) Arylalkylpiperidine-4-yl)methyl]-2-alpha-3,4,5-tetrahydro-1-(2H)-acenaphthylene-1-Onederivate, ein Verfahren für ihre Herstellung und ihre Verwendung als Medikamente
JP2665422B2 (ja) 置換された１，２，３，４−テトラヒドロシクロペント〔ｂ〕インドール、１，２，３，３ａ，４，８ａ−ヘキサヒドロシクロペント〔ｂ〕インドールおよび関連化合物
DE69130196T2 (de) 1-(Substituierte Pyridinylamino)-1H-indol-5-yl substituierte Carbamate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE3002367A1 (de) 2-substituierte trans-5-aryl-2,3,4,4a,5, 9b-hexahydro-1h-pyrido eckige klammer auf 4,3-b eckige klammer zu indole
DE69817557T2 (de) Piperidine derivate als inhibitoren der neurotransmitter-wiederaufbaunahme
DE69329084T2 (de) Benzoxazepin-Derivate als Cholinesterase-Inhibitoren
DE69403015T2 (de) Tetrahydrocyclopent[b]indole-methanamine und verwandte Verbindungen, und Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE68918402T2 (de) 1,2,3,4-Tetrahydro-1,9-Acridindiamine, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente.
DE68902386T2 (de) N-pyridinyl-9h-carbazol-9-amine, verfahren zu ihrer herstellung und ihre verwendung als medikamente.
DE69219801T2 (de) 9-Aminotetrahydroakridinederivate und verwandte Derivate, Verfahren zur ihrer Herstellung und ihre Anwendung als Arzneimittel
DE3851643T2 (de) 9-Amino-1,4-äthano-1,2,3,4-tetrahydroacridin und verwandte Verbindungen, Zwischenprodukte, ein Verfahren zur Herstellung davon und ihre Verwendung als Arzneimittel.
DE69014730T2 (de) (1,2,3,4-Tetrahydro-9-acridinimino)cyclohexan-Carbonsäure und verwandte Verbindungen, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente.
DD299425A5 (de) Neue 4,4-disubstituierte piperidin-derivate und verfahren zu ihrer herstellung
DE68914600T2 (de) Kondensierte heterocyclische Derivate von 1,2,3,4-Tetrahydroacridin, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition